Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework
Excerpt
The availability and use of appropriate Process Analytical Technology (PAT) is fundamental to achieving the transformed style of pharmaceutical manufacture that is envisaged by the regulators. [...]
Share and Cite
LOOSER, B.; VAISMAN, A.; BLASCO, A. Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework. Sci. Pharm. 2010, 78, 572. https://doi.org/10.3797/scipharm.cespt.8.LPAT01
LOOSER B, VAISMAN A, BLASCO A. Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework. Scientia Pharmaceutica. 2010; 78(3):572. https://doi.org/10.3797/scipharm.cespt.8.LPAT01
Chicago/Turabian StyleLOOSER, B., A. VAISMAN, and A. BLASCO. 2010. "Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework" Scientia Pharmaceutica 78, no. 3: 572. https://doi.org/10.3797/scipharm.cespt.8.LPAT01
APA StyleLOOSER, B., VAISMAN, A., & BLASCO, A. (2010). Real Time Measurement of Particle Size as a Response to the FDA's PAT Regulatory Framework. Scientia Pharmaceutica, 78(3), 572. https://doi.org/10.3797/scipharm.cespt.8.LPAT01